|Bid||0.00 x 800|
|Ask||16.15 x 1300|
|Day's Range||14.33 - 16.21|
|52 Week Range||4.16 - 16.30|
|Beta (5Y Monthly)||1.78|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||28.78|
Marinus Pharma. to present updates and data from its trials in CDKL5 and refractory status epileptics at American Epilepsy Society's conference.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shareholders will have a reason to smile today, with the analysts making...
Investors in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) had a good week, as its shares rose 5.4% to close at US$14.60...